Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.

Zheng, Jie, Haberland, Valeriia, Baird, Denis, Walker, Venexia, Haycock, Philip, Hurle, Mark, Gutteridge, Alex, Erola, Pau +26 more·2019·Nature Genetics
DOI 10.1101/627398

Cited by (834)

Items 301–400 of 834

  1. Drug repurposing opportunities for chronic kidney disease
    Xiong Chen, Runnan Shen, Dongxi Zhu, Shulu Luo, Guochang You, Ruijie Li, Xiaosi Hong, Ruijun Li, Jihao Wu, Yinong Huang et al. · 2024 · iScience
  2. Plasma proteometabolome in lung cancer: exploring biomarkers through bidirectional Mendelian randomization and colocalization analysis
    Bo Dong, Mengyao Wang, Kaixiu Li, Zuwei Li, Lunxu Liu, Shensi Shen · 2024 · Human Molecular Genetics
  3. Identification of Potential Drug Targets for Myopia Through Mendelian Randomization
    Yimin Qin, Chengcheng Lei, Tianfeng Lin, Xiaotong Han, Decai Wang · 2024 · Investigative Ophthalmology & Visual Science
  4. Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease
    Pin Zhao, Zhenhao Li, Shilong Xue, Jinshan Cui, Yonghao Zhan, Zhaowei Zhu, Xuepei Zhang · 2024 · Scientific Reports
  5. Mendelian Randomization Analysis Reveals Causal Effects of Plasma Proteome on Body Composition Traits
    Bai‐Xue Han, Shanshan Yan, Qian Xu, Jing‐Jing Ni, Xin‐Tong Wei, Gui-Juan Feng, Hong Zhang, Bin Li, Lei Zhang, Yu‐Fang Pei · 2021 · The Journal of Clinical Endocrinology & Metabolism
  6. Little genomic support for Cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers
    Emma Louise Anderson, Dylan M. Williams, Venexia M. Walker, Neil M Davies · 2022 · Scientific Reports
  7. Role of DNA methylation in the relationship between glioma risk factors and glioma incidence: a two-step Mendelian randomization study
    Amy Howell, Caroline L. Relton, Richard Michael Martin, Jie Zheng, Kathreena Mary Kurian · 2023 · Scientific Reports
  8. Genetically Proxied Therapeutic Effect of Metformin Use, Blood Pressure, and Hypertension’s Risk: a Drug Target-Based Mendelian Randomization Study
    Junhong Jiang, Di Hu, Qi Zhang, Zenan Lin, on behalf of The μ-Biomedical Data Investigation Group (Mu-BioDig) · 2023 · Journal of Cardiovascular Translational Research
  9. The association between ACE inhibitors and psoriasis based on the drug-targeted Mendelian randomization and real-world pharmacovigilance analyses
    Qiubai Jin, Feihong Ren, Ping Song · 2023 · Expert Review of Clinical Pharmacology
  10. Potential drug targets for gastroesophageal reflux disease and Barrett’s esophagus identified through Mendelian randomization analysis
    Yun-Lu Lin, Tao Yao, Yingwei Wang, Zhixiang Zhou, Ze‐Chao Hong, Yu Shen, Yu Yan, Yuechun Li, Jiafeng Lin · 2024 · Journal of Human Genetics
  11. An Analysis of Cellular Communication Network Factor Proteins as Candidate Mediators of Postpartum Psychosis Risk
    William Davies · 2019 · Frontiers in Psychiatry
  12. Nanoparticle enriched mass spectrometry proteomics in British South Asians identifies novel variant-protein-disease mechanisms
    Pietzner, Maik, Williamson, Alice, Hunt, Karen A., Koprulu, Mine, Kohleick, Leonhard, Demircan, Kamil, Genes & Health Research Team, Finer, Sarah, Zanini, Julia Carrasco, van Heel, David A et al. · 2025
  13. Comprehensive analysis of single-cell transcriptomics and genetic factors reveals the mechanisms and preventive strategies for the progression from pulmonary fibrosis to lung cancer
    Jinghua Gu, Jiansheng Xu, Annan Jiao, Ningning Cai, Tianrui Gu, Pengcheng Wu, Xinyu Cheng, Bo Chen, Yang Chen, Xiaoying Liu · 2024 · International Immunopharmacology
  14. Mendelian randomization analysis to identify potential drug targets for osteoarthritis
    Chenqi Lu, Yanan Xu, Shuai Chen, Li Guo, Pengcui Li, Xiaochun Wei, Xueqin Rong · 2025 · PLoS ONE
  15. Proteome-wide Mendelian randomization identifies causal plasma proteins in prostate cancer development
    Jian Hui Wu, Zitong Yang, Jiafeng Ding, Sida Hao, Hong Chen, Ke Jin, Cheng Zhang, Xiangyi Zheng · 2025 · Human Genomics
  16. Proteome‐Wide Mendelian Randomization Identifies Candidate Causal Proteins for Cardiovascular Diseases
    Chen Li, Nicolas De Jay, Shanshan Zhang, Xin De Fang, Supriya Sharma, Katrina A. Catalano, Venkatesh Sridharan, Zhaoqing Wang, Lei Zhao, Joseph D. Szustakowski et al. · 2025 · Advanced Genetics
  17. Mendelian randomization with proxy exposures: challenges and opportunities
    Ida Rahu, Ralf Tambets, Eric B. Fauman, Kaur Alasoo · 2025 · Genetics
  18. Mendelian randomization study implicates inflammaging biomarkers in retinal vasculature, cardiovascular diseases, and longevity
    Ana Villaplana-Velasco, Nicolas Perrot, Yu Huang, Michael Chong, Emanuele Trucco, Muthu Rama Krishnan Mookiah, Walter Nelson, Jeremy Petch, Hertzel C. Gerstein, Parminder Raina et al. · 2025 · Science Advances
  19. Integrating Single‐Cell Transcriptome‐Wide Mendelian Randomization and Differentially Expressed Gene Analyses to Prioritize Dynamic Immune‐Related Drug Targets for Cancers
    Jie Zheng, Qian Yang, Haoyu Liu, Huiling Zhao, Shuangyuan Wang, Yi Liu, Xueyan Wu, Yilan Ding, Hui Ying, Yifan Ye et al. · 2025 · Advanced Science
  20. The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study
    Xingxing Yu, Yanyu Zhang, Yuxiang Lin, Shuqing Zou, Pingxiu Zhu, Mengjie Song, Fangmeng Fu, Haomin Yang · 2023 · Frontiers in Genetics
  21. Genetic determinants of complement activation in the general population
    Damia Noce, Luisa Foco, Dorothea Orth‐Höller, Eva König, Giulia Barbieri, Maik Pietzner, Dariush Ghasemi-Semeskandeh, Stefan Coassin, Christian Fuchsberger, Martin Gögele et al. · 2023 · Cell Reports
  22. Integrated causal inference modeling uncovers novel causal factors and potential therapeutic targets of Qingjin Yiqi granules for chronic fatigue syndrome
    Junrong Li, Xiaobing Zhai, Jixing Liu, Chi Kin Lam, Weiyu Meng, Yuefei Wang, Shu Li, Yapeng Wang, Kefeng Li · 2024 · Acupuncture and Herbal Medicine
  23. Unveiling new protein biomarkers and therapeutic targets for acne through integrated analysis of human plasma proteomics and genomics
    Sui Deng, Rui Mao, Yifeng He · 2024 · Frontiers in Immunology
  24. Integrated Mendelian randomization and single-cell RNA-sequencing analyses identified OAS1 as a novel therapeutic target for erectile dysfunction via targeting fibroblasts
    Yi Wang, Guihua Chen, Li Deng · 2024 · Biology Direct
  25. Integrative Proteogenomic Analyses Provide Novel Interpretations of Type 1 Diabetes Risk Loci Through Circulating Proteins
    Tianyuan Lu, Despoina Manousaki, Lei Sun, Andrew D. Paterson · 2025 · Diabetes
  26. Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy
    Chenxin Ke, Yuefeng Yu, Jiang Li, Yuetian Yu, Ying Sun, Yuying Wang, Bin Wang, Yingli Lu, Mengjun Tang, Ningjian Wang et al. · 2025 · ImmunoTargets and Therapy
  27. Common Regulatory Mechanisms Mediated by Cuproptosis Genes in Inflammatory Bowel Disease and Major Depressive Disorder
    Jisen Shi, Qianyi Wu, Mengmeng Sang, Liming Mao · 2025 · Genes
  28. Exploring the pathways linking fasting insulin to coronary artery disease: a proteome-wide Mendelian randomization study
    Xin Huang, Jie V. Zhao · 2025 · BMC Medicine
  29. Progress and Research Priorities in Imaging Genomics for Heart and Lung Disease: Summary of an NHLBI Workshop
    Matthew Gregory Nayor, Li Shen, Gary Matthew Hunninghake, Peter Kochunov, R. Graham Barr, David A. Bluemke, Ulrich Broeckel, Peter D. Caravan, Susan C. Cheng, Paul S. de Vries et al. · 2021 · Circulation Cardiovascular Imaging
  30. Genetic control of body weight by the human brain proteome
    Éloi Gagnon, Arnaud S. Girard, Émilie Gobeil, Jérôme Bourgault, Christian Yves Couture, Patricia L. Mitchell, Claude Bouchard, Angelo Tremblay, Patrick Mathieu, Andréanne Michaud et al. · 2023 · iScience
  31. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis
    Zhihang Su, Qijun Wan · 2024 · Frontiers in Immunology
  32. Proteomic analysis reveals potential therapeutic targets for childhood asthma through Mendelian randomization
    Yiqing Wu, Yixin Cai, Xiaoli Chen, Shang‐Qin Chen, Xiu‐Feng Huang, Zhenlang Lin · 2024 · Clinical and Translational Allergy
  33. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening
    Weichen Yuan, Wei Xu, Xin Xu, Bo Qu, Fangkun Zhao · 2024 · Scientific Reports
  34. Integrative Post-Genome-Wide Association Study Analyses Relevant to Psychiatric Disorders: Imputing Transcriptome and Proteome Signals
    Hüseyin Gedik, Roseann Elizabeth Peterson, Brien P. Riley, Vladimir I. Vladimirov, Silviu‐Alin Bacanu · 2023 · Complex Psychiatry
  35. Correspondence on ‘Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study‘
    Ran Cui, Qiang Tong, Zhiyong Chen, Miao Chen, Sheng‐Ming Dai · 2020 · Annals of the Rheumatic Diseases
  36. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
    María Gordillo‐Marañón, Magdalena Zwierzyna, Pimphen Charoen, Fotios Drenos, Sandesh Chopade, Tina Shah, Jorgen Engmann, Juan Pablo Casas, Nish Chaturvedi, Olia Papacosta et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Hypothesis-free detection of gene-interaction effects on biomarker concentration in UK Biobank using variance prioritisation
    Matthew Lyon, Louise A C Millard, George Davey Smith, Tom R. Gaunt, Kate M. Tilling · 2022 · medRxiv
  38. Systematic disease-agnostic identification of therapeutically actionable targets using the genetics of human plasma proteins
    Mohd Anisul Karim, Bruno Ariano, Jeremy Schwartzentruber, Juan María Roldán‐Romero, Edward Mountjoy, James D. Hayhurst, Annalisa Buniello, Elmutaz Shaikho Elhaj Mohammed, Miguel Carmona, Michael Vaclav Holmes et al. · 2023 · medRxiv
  39. An accurate genetic colocalization method for the HLA locus
    Guillaume Butler‐Laporte, Tianyuan Lu, Sam Morris, Wenmin Zhang, Gavin Band, Fergus Hamilton, Amanda Yoon-Yee Chong, Kuang Lin, Ruth Nanjala, John Brent Richards et al. · 2024 · medRxiv
  40. Gene discovery and pleiotropic architecture of Chronic Pain in a Genome-wide Association Study of >1.2 million Individuals
    Sylvanus Toikumo, Christal N. Davis, Zeal Jinwala, Yousef Khan, Mariela V. Jennings, Lea Karatheodoris Davis, Sandra Sanchez‐Roige, Rachel L. Kember, Henry R. Kranzler · 2025 · medRxiv
  41. Cross-Tissue Regulatory Network Analyses Reveal Novel Susceptibility Genes and Potential Mechanisms for Endometriosis
    Mingrui Zou, Mingmei Lin, Kai-Lun Hu, Rong Li · 2024 · Biology
  42. PSMB4: a potential biomarker and therapeutic target for depression, perspective from integration analysis of depression GWAS data and human plasma proteome
    Jie-Wei Liu · 2025 · Translational Psychiatry
  43. Association of Plasma Angiogenin With Risk of Incident End-Stage Kidney Disease in Individuals With Type 2 Diabetes
    Resham L Gurung, Jianjun Liu, Sylvia Liu, Janus Lee, Huili Zheng, Clara Chan, Keven Ang, Su Chi Lim · 2025 · Diabetes
  44. Integrative Analysis of Plasma Proteomics and Transcriptomics Reveals Potential Therapeutic Targets for Psoriasis
    Hesong Wang, Chenguang Wang, Ruihao Qin, Jia He, Xuan Zhang, Chenjing Ma, Li Shi, Lijun Fan, Liuying Wang, Lei Cao · 2025 · Biomedicines
  45. Exploring the impact of coffee consumption and caffeine intake on cognitive performance in older adults: a comprehensive analysis using NHANES data and gene correlation analysis
    Jinrui Li, Kai Yu, Fan Bu, Peng Li, Lei Hao · 2025 · Nutrition Journal
  46. Circulating Protein Mediators Linking Genetically Predicted Smoking to Abdominal Aortic Aneurysm: A Genomic-Proteomic Analysis
    Shuai Yuan, Samuel Khodursky, Jiawei Geng, Pranav Sharma, Joshua Michael Spin, Philip S. Tsao, Michael G. Levin, Scott M. Damrauer · 2025 · Arteriosclerosis Thrombosis and Vascular Biology
  47. Integrating multi-modal omics to identify therapeutic atherosclerosis pathways for coronary heart disease
    Sophie C. de Ruiter, Marion van Vugt, Chris Finan, Diederick E. Grobbee, Dominique P.V. de Kleijn, Gerard Pasterkamp, Hester M. den Ruijter, Ernest Diez Benavente, Sanne A. E. Peters, Amand Floriaan Schmidt · 2025 · EBioMedicine
  48. From plasma proteomics Mendelian Randomization to neuropathological validation: The potential role of CTSH-GRN-TMEM106B and TREM2-IL-34 networks of microglia in Alzheimer's disease.
    Yu-Hao Yuan, Shengnan Wang, Piao-Piao Lian, Zhong-Hao Yu, Xiang-Ting Gao, Yi-Jie Duan, Ling Mao, Yi-Wu Zhou · 2025 · European Journal of Pharmacology
  49. Multi-omics signatures of chronic inflammation across immune-related disease states
    Hui Li, Xiaolin Xie, Lirui Tang, Chuanben Chen, Jinluan Li · 2026 · Frontiers in Immunology
  50. Nanoparticle-enriched mass spectrometry proteomics in British South Asians identifies links between genetic variants, plasma protein levels and disease risk
    Maik Pietzner, Alice Williamson, Karen A. Hunt, Mine Koprulu, Leonhard Kohleick, Kamil Demircan, David A. van Heel, Sarah Finer, Julia Carrasco-Zanini, David A. van Heel et al. · 2026 · Nature Genetics
  51. Exploration of potential drug targets for Glaucoma by plasma proteome screening
    Zhiqi Wang, Huanyu Zhou, Fei Wang, Haishan Huang · 2024 · Journal of Proteomics
  52. Assessing Association Between Circulating Bilirubin Levels and the Risk of Frailty: An Observational and Mendelian Randomization Study
    Jun Wu, Jue Xu, Hao‐qi Zou, Yi‐jiang Ouyang, Shang‐jie Li, Liang Wu, Jie Zhang, Mingjuan Yin, Dong‐Qing Ye, Jindong Ni · 2024 · Journal of Cachexia Sarcopenia and Muscle
  53. Machine learning reveals connections between preclinical type 2 diabetes subtypes and brain health
    Yi Fan, Jing Yuan, Fei Han, Judith Somekh, Mor Peleg B, Fei Ling Wu, Zhilong Jia, Yi‐Cheng Zhu, Zhengxing Huang · 2025 · Brain
  54. (Apo)Lipoprotein Profiling with Multi‐Omics Analysis Identified Medium‐HDL‐Targeting PSRC1 with Therapeutic Potential for Coronary Artery Disease
    Yingmei Li, Sihan Wang, Ling Liu, Hao Cai, Yacan Huang, Mingjing Gao, Xiaogang Zhang, Qingqing Wu, Gaokun Qiu · 2025 · Advanced Science
  55. Uncovering drug targets for cluster headache through proteome-wide Mendelian randomization analysis
    Zhonghua Xiong, Zhi Kai Guo, Lei Zhao, Dong Qiu, Yanliang Mei, Xiaoshuang Li, Peng Zhang, Mantian Zhang, Geyu Liu, Tianshuang Gao et al. · 2025 · The Journal of Headache and Pain
  56. Glucagon-like peptide-1 receptor agonists, inflammation, and kidney diseases: evidence from Mendelian randomization
    Yu-Xuan Yao, Chen Tang, Feng‐Lei Si, Jicheng Lv, Su-Fang Shi, Shu‐Feng Zhou, Lijun Liu, Hong Zhang · 2025 · Renal Failure
  57. Multi-tissue expression and splicing data prioritise anatomical subsite- and sex-specific colorectal cancer susceptibility genes
    Emma Hazelwood, Daffodil M. Canson, Benedita Deslandes, Xue Min Wang, Pik Fang Kho, Danny Legge, Andrei‐Emil Constantinescu, Matthew A. Lee, David Timothy Bishop, Andrew Tan Chan et al. · 2025 · Nature Communications
  58. Elucidation of disease etiology by trans-layer omics analysis
    Yuya Shirai, Yukinori Okada · 2021 · Inflammation and Regeneration
  59. Integrated untargeted and targeted proteomics to unveil plasma prognostic markers for patients with acute paraquat poisoning: A pilot study
    Tianqi Zhang, Siqi Huang, Min Wang, Na Yang, Huaijun Zhu · 2023 · Food and Chemical Toxicology
  60. Uncovering novel drug targets for bipolar disorder: a Mendelian randomization analysis of brain, cerebrospinal fluid, and plasma proteomes.
    Tingting Jia, Tian-Cheng Liu, Shiyi Hu, Yongjun Li, Peixin Chen, Fengqin Qin, Yongji He, Feng Han, Cheng-Cheng Zhang · 2024 · Psychological Medicine
  61. Novel Protein Biomarkers and Therapeutic Targets for Type 1 Diabetes and Its Complications: Insights from Summary-Data-Based Mendelian Randomization and Colocalization Analysis
    Mingrui Zou, Jichun Yang · 2024 · Pharmaceuticals
  62. Prioritizing drug targets in systemic lupus erythematosus from a genetic perspective: a druggable genome-wide Mendelian randomization study
    Yuan Gao, Youtao Zhou, Zikai Lin, Fengzhen Chen, Haiyang Wu, Chusheng Peng, Yingying Xie · 2024 · Clinical Rheumatology
  63. Unveiling Novel Protein Biomarkers for Psoriasis Through Integrated Analysis of Human Plasma Proteomics and Mendelian Randomization
    Rui Mao, Tongtong Zhang, Ziye Yang, Ji Li · 2024 · Psoriasis Targets and Therapy
  64. Systematic proteome-wide Mendelian randomization to prioritize causal plasma proteins for skin cancers
    Masahiro Yoshikawa, Tomohiro Nakayama, Kensuke Asaba · 2024 · Communications Biology
  65. Genetic evidence for the causal association between programmed death-ligand 1 and lung cancer
    Zhao Yang, Rong Yu, Wei Deng, Weihu Wang · 2021 · Journal of Cancer Research and Clinical Oncology
  66. Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
    Julian Willett, Tianyuan Lu, Tomoko Nakanishi, Satoshi Yoshiji, Guillaume Butler‐Laporte, Sirui Zhou, Yossi Farjoun, John Brent Richards · 2023 · Human Genetics
  67. Realising the full potential of MR-PHeWAS in cancer
    Jack Bowden · 2020 · British Journal of Cancer
  68. COL6A3-derived endotrophin mediates the effect of obesity on coronary artery disease: an integrative proteogenomics analysis
    Satoshi Yoshiji, Tianyuan Lu, Guillaume Butler‐Laporte, Julia Carrasco-Zanini, Yiheng Chen, Kevin Y. H. Liang, Julian Willett, Chen‐Yang Su, Shidong Wang, Darin Adra et al. · 2023 · medRxiv
  69. Cohort Profile: The Mendelian Randomization in Pregnancy (MR-PREG) collaboration - Improving evidence for prevention and treatment of adverse pregnancy and perinatal outcomes
    Nancy McBride, Gemma Clayton, Ana Gonçalves Soares, Qian Yang, Tom A. Bond, Amy E. Taylor, Charikleia Chatzigeorgiou, Elisabeth Aiton, Jane West, Maria Christine Magnus et al. · 2025 · medRxiv
  70. An Introduction to Causal Inference Methods with Multi‐omics Data
    Minhao Yao, Zhonghua Liu · 2025 · Current Protocols
  71. UK Biobank: Transforming drug discovery and precision medicine
    Jelena Bešević, Saredo Said, Réka Nagy, Yalda Jamshidi, Christopher D. Whelan, Lauren Carson, Martin K. Rutter, Adam J. Lewandowski, Mark Effingham, Rory Collins et al. · 2025 · British Journal of Pharmacology
  72. Revealing the genetic architectures underlying organ-specific aging based on proteomic data
    Ren‐Jie Zhu, Yan Guo, Jiahao Wang, Ke Yu, Wei Shi, Wen Pan, Xian-lin Yu, Wei Chen, Shan‐Shan Dong, Tie‐Lin Yang · 2025 · Nature Communications
  73. Plasma proteomics and incident coronary heart disease
    Matthew P. Huber, Jennifer A. Brody, Colleen M. Sitlani, Thomas R. Austin, Usman A. Tahir, Shuliang Deng, Devendra Meena, JINGSHA CHEN, Kunihiro Matsushita, Christie Mitchell Ballantyne et al. · 2026 · Communications Medicine
  74. Uncovering Druggable Targets in Aortic Dissection: An Association Study Integrating Mendelian Randomization, pQTL, and Protein–Protein Interaction Network
    Daisong Jiang, Sihao Zheng, Xiaokang Xu, Honghua Yue, Weitao Liang, Zhong Wu · 2024 · Biomedicines
  75. Therapeutic targets for gastrointestinal diseases: proteome-wide Mendelian randomization and colocalization analyses
    Daqin Zhan, Zhihao Yang, Pengcheng Li, Jun Pan · 2024 · Postgraduate Medical Journal
  76. Evaluating the Causal Effect of Circulating Proteome on Glycemic Traits: Evidence From Mendelian Randomization
    Xing Xing, Siqi Xu, Yining Wang, Ziyuan Shen, Simin Wen, Yan Zhang, Guangfeng Ruan, Guoqi Cai · 2024 · Diabetes
  77. GNLY as A Novel Cis-eQTL and Cis-pQTL Mediated Susceptibility Gene in Suppressing Prostatitis. Mendelian Randomization Study
    Yi Wang, Hao Ji, Guihua Chen, Jianhua Zhou, Dongliang Zhang, Xiang Wang · 2024 · Archives of Medical Research
  78. Mendelian Randomization Estimates the Effects of Plasma and Cerebrospinal Fluid Proteins on Intelligence, Fluid Intelligence Score, and Cognitive Performance
    Wei Zhao, Xinyu Zhang, Feng Li, Yan Cheng · 2024 · Molecular Neurobiology
  79. Proteome-wide mendelian randomization identifies causal plasma proteins in interstitial lung disease
    Kunrong Yu, Wanying Li, Wenjie Long, Yijia Li, Yanting Li, Huili Liao, Jianhong Liu · 2025 · Scientific Reports
  80. Identification of potential druggable targets for endometriosis through Mendelian randomization analysis
    Peng Chen, Xin Chuan Wei, Xiaoke Li, Yihang Zhou, Qifang Liu, Ling Ouyang · 2025 · Frontiers in Endocrinology
  81. Integrated Single‐Cell Transcriptome and eQTL Analyses Reveal the Role of PZP in Aging and Chronic Kidney Disease
    Xinhui Huang, Cheng Gang Zhu, Shiqi Lv, Yulin Wang, Jiayi Wang, Shuangxin Yuan, Yue Yang, Xiaoqiang Ding, Xiaoyan Zhang · 2025 · The Journal of Gene Medicine
  82. Leveraging Proteomics and Proteogenomics for Understanding Osteoporosis and Other Musculoskeletal Diseases
    M. Hasebe, C. Su, D. Kiel, Satoshi Yoshiji · 2025 · Current Osteoporosis Reports
  83. Insight into telomere regulation: road to discovery and intervention in plasma drug-protein targets
    Kaixi Ding, Juejue Zhangwang, Ming Lei, Chunping Xiong · 2024 · BMC Genomics
  84. ENPP2 /Autotaxin: The potential drug target for alcoholic liver disease identified through Mendelian randomization analysis
    Peiqiong Luo, Xuefeng Yu · 2024 · Liver International
  85. Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses
    Min Cao, Bin Cui · 2024 · Cardiovascular Diabetology
  86. Identification of potential drug targets for insomnia by Mendelian randomization analysis based on plasma proteomics
    Ni Yang, Liangyuan Shi, Pengfei Xu, Fang Ren, Shimeng Lv, Chunlin Li, Xianghua Qi · 2024 · Frontiers in Neurology
  87. Leveraging pQTL-based Mendelian randomization to identify new treatment prospects for primary biliary cholangitis and primary sclerosing cholangitis
    Lei Dai, Yunyan Ye, Joseph Mugaanyi, Zetong Hu, Jing Li Huang, Changjiang Lu · 2024 · Aging
  88. Genetic association of glycemic traits and antihyperglycemic agent target genes with the risk of lung cancer: A Mendelian randomization study
    Wen Juan Sun, Xiaoyu Zhang, Ning Li, Yan He, Jianguang Ji, Deqiang Zheng · 2024 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  89. Causal Relationship Between Circulating Immune Cells and Recurrent Spontaneous Abortion: A Bidirectional Mendelian Randomization Study
    Hailin Yu, Xianyang Hu, Xixi Huang, Tingxuan Yin, Lu Liu, Chaoyan Yue, Meirong Du · 2024 · American Journal of Reproductive Immunology
  90. Identification of Novel Protein Biomarkers and Drug Targets for Acne Vulgaris by Integrating Human Plasma Proteome with Genome-Wide Association Data
    Dongrui Xu, Xiaoyi Yang, Wenjuan Wu, Jiankang Yang · 2024 · Journal of Inflammation Research
  91. Therapeutic targets for muscle weakness in older adults: proteome-wide Mendelian randomization and colocalization analyses
    Shuai-Kang Wang, Qijun Wang, Xuan Zhao, Peng Wang, Xiangyu Li, Wei Wang, Shibao Lu · 2024 · The journal of nutrition health & aging
  92. Using proteomics to identify the mechanisms underlying the benefits of statins on ischemic heart disease
    Jie V. Zhao, Junmeng Zhang · 2024 · npj Cardiovascular Health
  93. Understanding the Genetic Architecture of Vitamin Status Biomarkers in the Genome-Wide Association Study Era: Biological Insights and Clinical Significance
    William R. Reay, Erin D. Clarke, Clara Albiñana, Liang‐Dar Hwang · 2024 · Advances in Nutrition
  94. Proteome-Wide Mendelian Randomization Analysis to Identify Potential Plasma Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer Subtypes
    Qianhan Lin, Jiajia Li, Yating Sun, Zulimire Abudousalamu, Mengyang Xue, Liangqing Yao, Mo Chen · 2024 · International Journal of Women s Health
  95. Potential drug targets for asthma identified through mendelian randomization analysis
    Xingxuan Chen, Yu Shang, Danting Shen, Si Shi, Zhe Wen, Lijuan Li, Hong Chen · 2025 · Respiratory Research
  96. Potential biomarkers for predicting the risk of thyroid cancer in immunosenescence: a population-based and externally validated multi omics study
    Qian Li, Yuanyuan Zhao, Jiawei Yan, Chao He · 2025 · Frontiers in Oncology
  97. Seronegative Sicca Syndrome: Diagnostic Considerations and Management Strategies
    Yordanka Mincheva Basheva-Kraeva, Krasimir Iliev Kraev, Petar Angelov Uchikov, Maria Ilieva Kraeva, Bozhidar Krasimirov Hristov, Nina Staneva Stoyanova, Vesela Todorova Mitkova-Hristova, Borislav Ivanov, Stanislav S. Karamitev, Nina Koleva et al. · 2025 · Life
  98. Mendelian randomization analysis of plasma levels of CD209 and MICB proteins and the risk of varicose veins of lower extremities
    Alexandra S. Shadrina, Elizaveta E. Elgaeva, Ian B. Stanaway, Gail Pairitz Jarvik, Bahram Namjou, Wei‐Qi Wei, Joe Glessner, Hakon H. Hakonarson, Pradeep Suri, Yakov A. Tsepilov · 2022 · PLoS ONE
  99. Mendelian randomization: using genetic information in epidemiological studies (review)
    Denis Plotnikov · 2023 · RESEARCH RESULTS IN BIOMEDICINE
  100. Screening Plasma Proteins for the Putative Drug Targets for Carpal Tunnel Syndrome
    Bai‐Xue Han, Tian-Ye Huang, Qi‐Gang Zhao, Shanshan Yan, Qian Xu, Xin-Ling Ma, Yuan Luo, Yu‐Fang Pei · 2023 · Cellular and Molecular Neurobiology